KaloBios Pharmaceuticals is seeking bankruptcy court permission to buy rights to a drug that could be in line for a lucrative priority review voucher, a ticket for a fast trip through the regulatory process.
from WSJ.com: US Business http://ift.tt/1oI0CeN
via IFTTT
No comments:
Post a Comment